Finally, the pre-incubation of NHBECs with tiotropium or the treatment of ISs with anti-IL-17A Ab significantly reduced the effects of ISs from COPD (p < 0.001 and p < 0.001, respectively) (Fig. 4d). This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.